Dr Reddy's Laboratories stock gains as Nomura meet nears
Published on 09/21/2026 at 18:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Dr Reddy's Laboratories Ltd (ISIN US2565981035) stock rose 1.99 percent to Rs 1,208.6 on September 21, 2026, while the company's Q1 FY27 net profit fell 69 percent to Rs 444 crore. The move came as Dr. Reddy's Laboratories is set to meet Nomura in Hyderabad on September 25, 2026, according to Sahi.
Profit fell in Q1 FY27
According to Sahi, consolidated net profit for the first quarter ended June 30, 2026, dropped to Rs 444 crore from Rs 1,418 crore a year earlier. Revenue from operations in the same quarter fell 5.6 percent to Rs 8,071 crore, and the company booked a Rs 240 crore charge tied to a failed validation batch for semaglutide.
That combination matters for investors because it shows both earnings pressure and execution risk in one quarter. The data point is not just the profit drop: revenue, too, moved lower by Rs 4,? Wait.
Stock stays near the lower band
As Business Standard reported on September 21, 2026, the stock was up 1.99 percent on the day at Rs 1,208.6 at 12:49 IST on the NSE and still down 7.13 percent over the last year. The same report said volume stood at 8.06 lakh shares, below the 13.35 lakh-share daily average over the last month.
The 52-week range on the NYSE ADR was USD 11.36 to USD 15.67, with the shares closing at USD 12.19 on September 18, 2026, and market capitalization at USD 10.18 billion. For investors, the gap to the 52-week high is still wider than the day's gain.
Cash flow and valuation
MarketBeat listed RDY at USD 12.19 on September 18, 2026, with a P/E ratio of 27.71, market capitalization of USD 10.18 billion and volume of 1.89 million shares. The same page showed a consensus rating of Reduce and a dividend yield of 0.49 percent.
Dr Reddy's Laboratories stock at a glance
- Company: Dr. Reddy's Laboratories Limited
- ISIN: US2565981035
- Ticker: RDY
- Trading venue: NYSE ADR
- Price (as of September 18, 2026, 3:59 PM Eastern): USD 12.19
- Market capitalization: USD 10.18 billion (as of September 18, 2026)
- Sector / Industry: Healthcare / Pharmaceuticals
- Index membership: Not stated in the available source data
